Picture of Core One Labs logo

COOL Core One Labs Share Price

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m+28.66%
3m-31.67%
6m-34.84%
1yr-47.53%
Volume Change (%)
10d/3m-53.25%
Price vs... (%)
52w High-65.44%
50d MA-8.38%
200d MA-34.35%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-43.32%
Return on Equity-39.53%
Operating Margin-677.35%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202431st Mar 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Core One Labs EPS forecast chart

Profile Summary

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. The Company, through its wholly owned subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics.

Directors

Last Annual
March 31st, 2023
Last Interim
December 31st, 2023
Incorporated
September 14th, 2010
Public Since
August 17th, 2011
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
ca flag iconCanadian Securities Exchange
Shares in Issue
47,097,332
Blurred out image of a map
Address
595 Burrard Street, Suite 3123, VANCOUVER, V7X 1J1
Web
https://core1labs.com/
Phone
+1 6046480522
Auditors
DALE MATHESON CARR-HILTON LABONTE LLP

COOL Share Price Performance

Upcoming Events for COOL

Core One Labs Inc Annual Shareholders Meeting

Similar to COOL

Picture of 1933 Industries logo

1933 Industries

ca flag iconCanadian Securities Exchange

Picture of 1CM logo

1CM

ca flag iconCanadian Securities Exchange

Picture of Acreage Holdings logo

Acreage Holdings

ca flag iconCanadian Securities Exchange

Picture of Adastra Holdings logo

Adastra Holdings

ca flag iconCanadian Securities Exchange

Picture of Aion Therapeutic logo

Aion Therapeutic

ca flag iconCanadian Securities Exchange

FAQ